Every finding on crocin-1
14 findings, by evidence strength
14 shown
- Pittsburgh Sleep Quality Index global scoreMoved: lowersEvidence: ModeratePaper: PMID 307957852019
- Who
- Patients under methadone maintenance treatment (methadone in both arms); crocin 30 mg/day versus placebo
- Dose studied
- 30 mg/day crocin (15 mg twice daily)
After 8-week intervention, crocin significantly decreased Beck Depression Inventory (b - 6.66; 95% CI, - 9.88, - 3.45; P < 0.0001), Beck Anxiety Inventory (b - 4.35; 95% CI, - 5.94, - 2.75; P < 0.0001), general health questionnaire (b - 4.45; 95% CI, - 7.68, - 1.22; P = 0.008) and Pittsburgh Sleep Quality Index (b - 2.73; 95% CI, - 3.74, - 1.73; P < 0.0001) in patients under MMT, compared with the placebo.”
Quoted verbatim from The effects of crocin on psychological parameters in patients under methadone maintenance treatment: a randomized clinical trial.RCT · 8 weeksPermalink - TriglyceridescontestedMoved: lowersEvidence: ModeratePaper: PMID 362090912022
- Who
- Adults with type 2 diabetes and microalbuminuria on routine antidiabetic, antihypertensive and lipid-lowering care; crocin 15 mg/day versus placebo
- Dose studied
- 15 mg crocin tablet daily
As listed in Table 2, comparison of the crocin and placebo groups for changes in variables (before- after) showed that mean serum TG levels decreased significantly in the crocin group compared with the increasing values in the placebo group (P-Value = 0.03).”
Quoted verbatim from Evaluation of therapeutic effects of crocin in attenuating the progression of diabetic nephropathy: a preliminary randomized triple-blind placebo-controlled trial.RCT · 3 monthsPermalink - Beck Depression Inventory (BDI) total scoreMoved: lowersEvidence: ModeratePaper: PMID 307957852019
- Who
- Patients under methadone maintenance treatment (methadone in both arms); crocin 30 mg/day versus placebo
- Dose studied
- 30 mg/day crocin (15 mg twice daily)
After 8-week intervention, crocin significantly decreased Beck Depression Inventory (b - 6.66; 95% CI, - 9.88, - 3.45; P < 0.0001), Beck Anxiety Inventory (b - 4.35; 95% CI, - 5.94, - 2.75; P < 0.0001), general health questionnaire (b - 4.45; 95% CI, - 7.68, - 1.22; P = 0.008) and Pittsburgh Sleep Quality Index (b - 2.73; 95% CI, - 3.74, - 1.73; P < 0.0001) in patients under MMT, compared with the placebo.”
Quoted verbatim from The effects of crocin on psychological parameters in patients under methadone maintenance treatment: a randomized clinical trial.RCT · 8 weeksPermalink - Fasting blood glucoseMoved: lowersEffect, as reportedMD−6.52[−11.96 to −1.08]Evidence: Very limitedPaper: PMID 329517482020
- Who
- Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
- Dose studied
- not reported
Results of the pooled random-effect size analysis showed just a significant decreasing effect of crocin supplementation on FBG (WMD: -6.52 mg/l, 95 % CI, -11.96, -1.08; p = 0.019) and TC (WMD: -4.64 mg/l, 95 % CI, -8.19, -1.09; p = 0.010).”
Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink - Total cholesterol (TC)Moved: lowersEffect, as reportedMD−4.64[−8.19 to −1.09]Evidence: Very limitedPaper: PMID 329517482020
- Who
- Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
- Dose studied
- not reported
Results of the pooled random-effect size analysis showed just a significant decreasing effect of crocin supplementation on FBG (WMD: -6.52 mg/l, 95 % CI, -11.96, -1.08; p = 0.019) and TC (WMD: -4.64 mg/l, 95 % CI, -8.19, -1.09; p = 0.010).”
Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink - LDL cholesterolMoved: no difference foundEvidence: Very limitedPaper: PMID 329517482020
- Who
- Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
- Dose studied
- not reported
Crocin supplements did not have any significant effect on serum TG (p = 0.144) levels, LDL-C (p = 0.161), and HDL-C (p = 0.872) levels.”
Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink - TriglyceridescontestedMoved: no difference foundEvidence: Very limitedPaper: PMID 329517482020
- Who
- Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
- Dose studied
- not reported
Crocin supplements did not have any significant effect on serum TG (p = 0.144) levels, LDL-C (p = 0.161), and HDL-C (p = 0.872) levels.”
Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink - C-reactive protein concentrationMoved: lowersEvidence: Very limitedreplicated ×1Paper: PMID 383068882024
- Who
- Patients with multiple sclerosis; crocin 15 mg twice daily (30 mg/day) versus placebo
- Dose studied
- 15 mg crocin tablet twice daily (30 mg/day)
The data analysis using ANCOVA showed that supplementation with crocin for 8 weeks significantly lowered hs-CRP levels (p-value= 0.01).”
Quoted verbatim from Effects of crocin on inflammatory biomarkers and mental health status in patients with multiple sclerosis: A randomized, double-blinded clinical trial.RCT · 8 weeksPermalink - C-reactive protein concentrationMoved: lowersEffect, as reportedSMD−0.5[−0.86 to −0.13]Evidence: Very limitedreplicated ×1Paper: PMID 396326022025
- Who
- Adults supplemented with crocin in pooled randomised clinical trials
- Dose studied
- not reported
Our findings indicated that crocin supplementation significantly reduced c-reactive protein (CRP) levels (SMD: -0.50; 95%CI: -0.86 to -0.13; p = 0.008), tumor necrosis factor-α (TNF-α) (SMD: -1.96; 95%CI: -2.72 to -1.19; p < 0.001), and interleukin-6 (IL-6) (SMD: -3.52; 95%CI: -6.84 to -0.20; p = 0.03).”
Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink - Tumour necrosis factor alpha concentrationMoved: lowersEffect, as reportedSMD−1.96[−2.72 to −1.19]Evidence: Very limitedPaper: PMID 396326022025
- Who
- Adults supplemented with crocin in pooled randomised clinical trials
- Dose studied
- not reported
Our findings indicated that crocin supplementation significantly reduced c-reactive protein (CRP) levels (SMD: -0.50; 95%CI: -0.86 to -0.13; p = 0.008), tumor necrosis factor-α (TNF-α) (SMD: -1.96; 95%CI: -2.72 to -1.19; p < 0.001), and interleukin-6 (IL-6) (SMD: -3.52; 95%CI: -6.84 to -0.20; p = 0.03).”
Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink - Total antioxidant capacityMoved: raisesEffect, as reportedSMD1.48[0.52 to 2.43]Evidence: Very limitedPaper: PMID 396326022025
- Who
- Adults supplemented with crocin in pooled randomised clinical trials
- Dose studied
- not reported
Also, crocin supplementation led to a significant increase in total antioxidant capacity (TAC) (SMD: 1.48; 95%CI: 0.52 to 2.43; p = 0.002).”
Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink - Interleukin-6 concentrationMoved: lowersEffect, as reportedSMD−3.52[−6.84 to −0.2]Evidence: Very limitedPaper: PMID 396326022025
- Who
- Adults supplemented with crocin in pooled randomised clinical trials
- Dose studied
- not reported
Our findings indicated that crocin supplementation significantly reduced c-reactive protein (CRP) levels (SMD: -0.50; 95%CI: -0.86 to -0.13; p = 0.008), tumor necrosis factor-α (TNF-α) (SMD: -1.96; 95%CI: -2.72 to -1.19; p < 0.001), and interleukin-6 (IL-6) (SMD: -3.52; 95%CI: -6.84 to -0.20; p = 0.03).”
Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink - HDL cholesterolMoved: no difference foundEvidence: Very limitedPaper: PMID 329517482020
- Who
- Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
- Dose studied
- not reported
Crocin supplements did not have any significant effect on serum TG (p = 0.144) levels, LDL-C (p = 0.161), and HDL-C (p = 0.872) levels.”
Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink - Malondialdehyde (circulating)Moved: no difference foundEvidence: Very limitedPaper: PMID 396326022025
- Who
- Adults supplemented with crocin in pooled randomised clinical trials
- Dose studied
- not reported
Overall effect size showed that crocin intake failed to change the erythrocyte sedimentation rate (ESR) and malondialdehyde (MDA) levels significantly.”
Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink
No row matches these filters.
No dose is advised.